Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
Elaheh Salardini(Roozbeh Hospital), Shahin Akhondzadeh(Roozbeh Hospital), Payam Mohammadinejad(Roozbeh Hospital), Nagmeh Zahraei(Roozbeh Hospital), Atefeh Zeinoddini(Massachusetts General Hospital)
Cited by 55
Related Papers
A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence–Powered Ultrasound for Improving Clinical Workflow
|Journal of the American College of Radiology|2019|319
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
|Journal of Affective Disorders|2013|135
RIL-Contour: a Medical Imaging Dataset Annotation Tool for and with Deep Learning
|Journal of Imaging Informatics in Medicine|2019|129